Showing results (111-120 of 1,877) with videos related to

Sort By:
Pageof 188
Immunotherapy|May 25, 2021
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcomaHayato Kawachi, Kei Kunimasa, Yoji Kukita, et al.
Immunotherapy|August 2, 2021
Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair-deficient pancreatic cancerErica S Tsang, Evan J Walker, Julia Carnevale, et al.
Immunotherapy|June 26, 2020
A Phase I clinical trial of chimeric antigen receptor-modified T cells in patients with relapsed and refractory lymphomaXinfeng Chen, Xin Li, Yanfen Liu, et al.
Immunotherapy|June 24, 2015
MAGE-A3: an immunogenic target used in clinical practiceAli Esfandiary, Soudeh Ghafouri-Fard
Immunotherapy|May 19, 2020
Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumabAndrea Alberti, Maddalena Mancin, Diego Cortinovis, et al.
Immunotherapy|May 22, 2020
Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapyYu Zhao, Xiaorong Zhou
Immunotherapy|April 22, 2020
Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case reportYasuhiro Kato, Yasutaka Watanabe, Yuki Yamane, et al.
Immunotherapy|June 24, 2020
Differences between diffuse idiopathic skeletal hyperostosis and spondyloarthritisAmir Bieber, Ignazio Francesco Masala, Reuven Mader, et al.
Immunotherapy|May 26, 2021
Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in IsraelSarah Sharman Moser, Lior Apter, Ashwini Arunachalam, et al.
Immunotherapy|November 30, 2022
Neoadjuvant immunochemotherapy in the treatment of nonmetastatic muscle-invasive bladder cancer: a systematic reviewJulien Sarkis, Enguerrand Vannier, Georges Mjaess, et al.
Pageof 188